Please assess the completion status of the following clinical trial:

Trial Title: Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Currently enrolled in PrEP-PP study and on PrEP~2. 18+ years old~3. confirmed HIV-negative (confirmed with a 4th generation antigen HIV test)~4. confirmed to be postpartum (1-6 months postpartum)~5. confirmed to currently have a male partner~6. confirmed to have a cell phone that can read and respond to SMS/Whatsapp messages~Exclusion Criteria:~Failure to meet all of inclusion criteria

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Intervention (Type: EXPERIMENTAL): HIV self-testing kits and counseling on use for participant and partner use + enhanced adherence counseling including urine tenofovir test to provide biofeedback in women using PrEP
- Control (Type: NO_INTERVENTION): Standard of care intervention including facility based HIV testing, referral for partner to attend facility for testing, and PrEP adherence counseling without biofeedback

Based on this trial design, predict the completion outcome and termination type (if applicable).